MRPL52 and breast cancer: ChIP assays further showed apparent fold enrichment of HIF-1α and HIF-1β on the putative sites HRE1 and HRE2 of MRPL52 promoter compared to the IgG control in BC cells exposed to 1% O2 (Figure S1E).